Investigation of the effect of the incretin on cardiac function in patients with type 2 diabetes
Phase 4
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000014725
- Lead Sponsor
- Division of diabetes, Mitsui Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Allergy of Incretin related drug 2) Patients who receive DPP4 inhibitors or GLP-1 before starting study 3) Pregnant, lactating, possibly pregnant or planning to become pregnant women 4) Renal, hepatic, cardiovascular, thyroid, or hematological disease. 5) Malignant tumor 6) Patients considered as inadequate by the principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method